Edition:
United Kingdom

Insider Trading: Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

120.32USD
24 Jun 2019
Change (% chg)

$-1.06 (-0.87%)
Prev Close
$121.38
Open
$122.99
Day's High
$122.99
Day's Low
$119.38
Volume
92,152
Avg. Vol
104,434
52-wk High
$194.56
52-wk Low
$105.19

All Insider Trades
Trading Date Name Title Type Shares Traded Price
21 May 2019

Huang (Jane)

Officer Sell 2,200 $130.06
21 May 2019

Huang (Jane)

Officer Buy 2,200 $45.31
21 May 2019

Liang (Howard)

Chief Financial Officer Sell 23,200 $130.21
21 May 2019

Liang (Howard)

Chief Financial Officer Buy 301,600 $0.50
20 May 2019

Huang (Jane)

Officer Sell 300 $130.12
20 May 2019

Huang (Jane)

Officer Buy 300 $45.31
13 May 2019

Glazer (Donald Wayne)

Director Sell 15,027 $125.11
6 May 2019

Liang (Howard)

Chief Financial Officer Buy 1,800 $6.50
6 May 2019

Liang (Howard)

Chief Financial Officer Sell 1,800 $130.01
1 May 2019

Oyler (John Victor)

Chief Executive Officer Sell 1,402 $124.79
1 May 2019

Wu (Xiaobin)

Officer Sell 113 $125.55
1 May 2019

Wu (Xiaobin)

Officer Sell 5,657 $124.47
1 May 2019

Oyler (John Victor)

Chief Executive Officer Sell 51 $126.54
1 May 2019

Wu (Xiaobin)

Officer Sell 185 $125.43
1 May 2019

Oyler (John Victor)

Chief Executive Officer Sell 1,371 $125.53
8 Apr 2019

Huang (Jane)

Officer Buy 14,130 $29.49
8 Apr 2019

Huang (Jane)

Officer Sell 6,159 $142.73
8 Apr 2019

Huang (Jane)

Officer Sell 800 $140.49
8 Apr 2019

Huang (Jane)

Officer Sell 3,439 $141.80
8 Apr 2019

Huang (Jane)

Officer Sell 147 $145.94
8 Apr 2019

Huang (Jane)

Officer Sell 2,304 $143.72
8 Apr 2019

Huang (Jane)

Officer Sell 1,281 $144.90
14 Mar 2019

Glazer (Donald Wayne)

Director Sell 14,973 $136.10
11 Mar 2019

Huang (Jane)

Officer Sell 2,565 $130.00
11 Mar 2019

Huang (Jane)

Officer Buy 2,565 $29.49

Institutional Holders

% Shares Owned: 82.72%
# of Holders: 348
Total Shares Held: 49,549,606
3 Mo. Net Change: 1,224,266
# New Positions: 52
# Closed Positions: 29
# Increased Positions: 171
# Reduced Positions: 109
# Net Buyers: 62

Officers & Directors

Name Age Since Current Position

John Oyler

50 2010 Executive Chairman of the Board, Chief Executive Officer

Xiaobin Wu

57 2018 General Manager, China and President

Howard Liang

55 2015 Chief Financial Officer and Chief Strategy Officer

Eric Hedrick

50 2019 Interim Chief Medical Officer, Immuno-Oncology

Jane Huang

45 2016 Chief Medical Officer, Hematology

Hing Ling Chau

44 2018 Company Secretary

Xiaodong Wang

55 2016 Non-Executive Director

Timothy Chen

61 2016 Non-Executive Independent Director

Donald Glazer

73 2013 Non-Executive Independent Director

Michael Goller

43 2015 Non-Executive Independent Director

Ranjeev Krishana

44 2014 Non-Executive Independent Director

Thomas Malley

50 2016 Non-Executive Independent Director

Jing-Shyh Su

66 2018 Non-Executive Independent Director

Qingqing Yi

46 2014 Non-Executive Independent Director